OBJECTIVE: Pregnancy-induced hypertension is an important cause of maternal mortality, intrauterine growth retardation, and perinatal mortality . We examined the relationship between pregnancy-induced hypertension and asthma. STUDY DESIGN : The study population consisted of 24,115 women without a history of chronic systemic hypertension who were delivered of live born and stillborn infants at Mount Sinai Medical Center between January 1987 and December 1991 . Pregnancy-induced hypertension was defined as blood pressure of at least 140/90 mm Hg or an increase of >-30 mm Hg in systolic pressure or >_ 15 mm Hg in diastolic pressure. RESULTS : There was a significant association between pregnancy-induced hypertension and asthma during pregnancy (X2 = 17.86, p < 0 .001) . In addition, there was a significant upward trend in the incidence of asthma during pregnancy in women without, with moderate, and with severe pregnancy-induced hypertension (Mantel-Haenszel X 2 = 11 .8, p = 0 .001) . Logistic regression analysis demonstrated that the association between pregnancy-induced hypertension and asthma during pregnancy persisted after adjustment for the confounding factors of race or ethnicity, maternal age, parity, and prepregnancy weight (adjusted odds ratio 2 .52, 95% confidence interval 1 .47 to 4 .35, p = 0 .0008) . An association between pregnancy-induced hypertension and a history of asthma was also found (X2 = 11 .2, p = 0 .001) . However, after adjustment for potential confounders, this association failed to achieve statistical significance (adjusted odds ratio 1 .2, 95% confidence interval 0 .97 to 1 .53, p = 0 .083) . CONCLUSION : Both pregnancy-induced hypertension and asthma might be caused by a third factor affecting smooth muscle reactivity . (AM J OBSTET GYNECOL 1993 ;168 :1463-6.) Key words : Pregnancy-induced hypertension, asthma Pregnancy-induced hypertension is a major cause of maternal mortality, intrauterine growth retardation, and perinatal mortality ." 2 Pregnancy-induced hypertension is also an important component of preeclampsia, a disorder of pregnancy characterized by hypertension, proteinuria, edema, and at times thrombocytopenia and disturbances of liver function . We report here that asthma during pregnancy may be a risk factor for pregnancy-induced hypertension .
Pregnancy-induced hypertension is a major cause of maternal mortality, intrauterine growth retardation, and perinatal mortality ." 2 Pregnancy-induced hypertension is also an important component of preeclampsia, a disorder of pregnancy characterized by hypertension, proteinuria, edema, and at times thrombocytopenia and disturbances of liver function . We report here that asthma during pregnancy may be a risk factor for pregnancy-induced hypertension .
Methods
The study population consisted of 24,115 women without a history of chronic systemic hypertension who were delivered of live born and stillborn infants at Mount Sinai Medical Center between January 1987 and December 1991 . The data were obtained from a computerized perinatal data base that includes detailed information on all patients who delivered at Mount Sinai Medical Center . The accuracy of data entry is periodically confirmed by reviewing selected patient records .
Asthma during pregnancy was defined as asthma that necessitated treatment . Pregnancy-induced hypertension was defined as blood pressure of at least 140/90 mm Hg or an increase of ? 30 mm Hg in systolic pressure or ? 15 mm Hg in diastolic pressure . Pregnancy-induced hypertension was classified as moderate if systolic blood pressure fell into the range of 140 to 160 mm Hg and diastolic blood pressure was 90 to 110 mm Hg . Pregnancy-induced hypertension was classified as severe if systolic pressure was > 160 mm Hg or diastolic pressure was > 110 mm Hg. Chronically hypertensive patients, that is, patients hypertensive before they became pregnant, were excluded from the analysis .
In addition to pregnancy-induced hypertension the variables assessed included maternal age, parity, race, prepregnancy weight, presence of gestational diabetes, history of asthma, and asthma during pregnancy . Be- cause black or Hispanic women might be at increased risk of pregnancy-induced hypertension and because these same women might also have increased risk of asthma, the influence of race or ethnicity and other potential confounders was controlled for by logistic regression analysis . Odds ratios, which approximate relative risks, were calculated for pregnancy-induced hypertension and for the other variables listed above . SEs were used to determine 95% confidence intervals . All statistical analyses were performed with the SAS system .'
Results
Of the 24,115 women studied, 1307 had moderate pregnancy-induced hypertension, and 92 had severe pregnancy-induced hypertension . Of the total number of women, 1435 had a history of asthma and 136 had asthma during pregnancy .
There was a significant association between pregnancy-induced hypertension and asthma during pregnancy (X 2 = 16 .7, p < 0 .001) . In addition, there was a significant upward trend in the incidence of asthma during pregnancy in women with no pregnancy-induced hypertension, moderate pregnancy-induced hypertension, and severe pregnancy-induced hypertension (Mantel-Haenszel X 2 = 11 .8, p = 0 .001, Fig . ,1) .
Analysis by logistic regression demonstrated that women with asthma during pregnancy were significantly more likely to have pregnancy-induced hypertenMay 1993 Am J Obstet Gynecol sion (adjusted odds ratio 2 .52, 95% confidence interval 1 .47 to 4 .35, p = 0 .0008) . This association was independent of the effects of the other independent variables : race, maternal age, parity, and prepregnancy weight (Table I) .
Because the data for this study were derived from a computerized data bank, the occurrence of asthma might be underreported . However, one would expect equal underreporting of pregnancy-induced hypertension .
An association between pregnancy-induced hypertension and a history of asthma was also found (X 2 = 11 .2, p = 0 .001) . However, after adjustment for potential confounders, this association failed to achieve statistical significance (adjusted odds ratio 1 .2, 95% confidence interval 0 .97 to 1 .53, p = 0 .083, Table II There are at least three possible explanations for the association of pregnancy-induced hypertension and asthma during pregnancy . One is that the medicines used to treat the asthma, specifically glucocorticoids, might cause the pregnancy-induced hypertension .
However, only aerosol glucocorticoids were used in the pregnant asthmatics we studied . Administered in this form, the glucocorticoid side effects are minimal . Also, glucocorticoids increase the risk of gestational diabetes . Because there was no correlation between gestational diabetes and asthma during pregnancy in our study, glucocorticoid use is unlikely to be a confounding variable . In addition, a study of 85 corticosteroid-dependent patients with respiratory disease showed that the prevalence of hypertension was not greater in these patients than in the general population .'°O ne wonders whether any women with pregnancyinduced hypertension were treated with aspirin . Aspirin might then be a confounding variable because of aspirin-induced asthma . However, use of aspirin during pregnancy in our patients was extremely rare . It was used as an anticoagulant in women with lupus, but these women were excluded from our study .
A second possible explanation for the association of pregnancy-induced hypertension and asthma during pregnancy is that the stress of the hypertension brings In summary, both pregnancy-induced hypertension and asthma are related to circulating substances that cause altered reactivity and constriction of smooth muscle. Of these substances, the leukotrienes are implicated in both conditions . Therefore it would be worthwhile to study further in women with pregnancy-induced hypertension these and perhaps other circulating bioactive mediators related to asthma . Also, the circulating factors associated with pregnancy-induced hypertension should be studied in asthmatics . Identification of the substances involved in both conditions could lead to a better understanding of the underlying mechanisms and to improved methods of treatment .
